Addiction Prevention and Responsible Opioid Practices Act

Fact Sheet API

Bill Number

HR 5865

Introduced

May 17, 2018

Latest Action

Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

Sponsor

Cosponsors

Topics

Alternative treatments Business ethics Business records Congressional oversight Drug safety, medical device, and laboratory regulation Drug therapy Drug trafficking and controlled substances Drug, alcohol, tobacco use Government information and archives Government studies and investigations Health Health care quality Health information and medical records Health personnel Health programs administration and funding Health promotion and preventive care Health technology, devices, supplies Hospital care Indian social and development programs Licensing and registrations Marketing and advertising Medical education Medical ethics Medicare Military medicine Minority health Prescription drugs Sales and excise taxes State and local government operations User charges and fees Veterans' medical care

Full Text

View Full Bill Text

Votes

Summary

Addiction Prevention and Responsible Opioid Practices Act

This bill establishes a series of requirements relating to opioid regulation, prescribing, and monitoring, including licensure requirements for pharmaceutical representatives, a national opioid drug mapping tool to monitor prescribing practices of Medicaid providers, and an excise tax on opioid manufacturers.

Actions

Jul 24, 2018

Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Jun 4, 2018

Referred to the Subcommittee on Health.
May 17, 2018

Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 17, 2018

Introduced in House

Amendments

Related Bills